Sage Journals: Discover world-class research

Open access

Review article

First published 2023-07-20

MET Inhibitors for Papillary Renal Cell Carcinoma

James Nicholas Brundage, Kamal Kant Sahu, Benjamin Louis Maughan

Kidney Cancer

Open access

Review article

First published 2019-11-01

A Review of Papillary Renal Cell Carcinoma and MET Inhibitors

Katherine Emilie Rhoades Smith, Mehmet Asim Bilen

Kidney Cancer

Open access

Research article

First published 2019

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations

Yanhua Wang, Manyi Xu, Ke Wang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2015-9

Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [ 99m Tc] (AH-113018) or CY 5** (AH-112543) Labeled Peptide

Elaine M. Jagoda, Sibaprasad Bhattacharyya, Joseph Kalen [...]

Molecular Imaging

Retricted access

Research article

First published 2013-12

In Vitro and In Vivo Activity of Cabozantinib (XL184),an Inhibitor of RET,MET,and VEGFR2,in a Model of Medullary Thyroid Cancer

Frauke Bentzien, Marcus Zuzow, Nathan Heald [...]

Thyroid®

Open access

Research article

First published 2017-11-27

Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107

Przemyslaw W. Twardowski, Catherine M. Tangen, Xiwei Wu [...]

Kidney Cancer

Free access

Research article

First published 2010-4

Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor

Shirley A. Aguirre, Jonathan R. Heyen, Walter Collette [...]

Toxicologic Pathology

Retricted access

Research article

First published 1993-6

Evaluation of the Use of Antisense tRNA met as an Inhibitor for Eukaryotic Protein Synthesis

Oleg Mirochnitchenko, Masayori Inouye

Nucleic Acid Therapeutics

Free access

Review article

First published 2011-7

The role of the c-Met pathway in lung cancer and the potential for targeted therapy

Martin Sattler, Rifat Hasina, Mamatha M. Reddy [...]

Therapeutic Advances in Medical Oncology

Search results